Results 331 to 340 of about 10,512,166 (412)
ICP34.5 is one of the most important antihost response proteins. The saRNA‐encoding HSV‐1 neurovirulence protein ICP34.5 clearly mediated the eukaryotic initiation factor 2 alpha subunit (eIF2α) dephosphorylation and significant suppression of innate immune responses in vitro, leading to enhanced expression of the saRNA‐encoded gene.
Xuemin Lu+6 more
wiley +1 more source
Decoding colorectal cancer targeted therapy: a bibliometric journey of the last decade (2015-2024). [PDF]
Zhou L+7 more
europepmc +1 more source
Long non‐coding RNAs (lncRNAs) occupy an abundant fraction of the eukaryotic transcriptome and an emerging area in cancer research. Regulation by lncRNAs is based on their subcellular localization in HNSCC. This cartoon shows the various functions of lncRNAs in HNSCC discussed in this review.
Ellen T. Tran+3 more
wiley +1 more source
Harnessing Oncolytic Viruses for Targeted Therapy in Triple-Negative Breast Cancer. [PDF]
Tang S+5 more
europepmc +1 more source
The impact of frailty syndrome on skeletal muscle histology: preventive effects of exercise
Frailty syndrome exacerbates skeletal muscle degeneration via increased ECM deposition and myofiber loss. This study, using a murine model, demonstrates that endurance exercise attenuates these histopathological alterations, preserving muscle integrity. Findings support exercise as a viable strategy to counteract frailty‐induced musculoskeletal decline
Fujue Ji+3 more
wiley +1 more source
Progress in the Application of Novel Nanomaterials in Targeted Therapy for Liver Cancer. [PDF]
Wei X+11 more
europepmc +1 more source
The role of circular RNAs in regulating cytokine signaling in cancer
Cytokines present in the tumor microenvironment fuel cancer development. Aberrant expression of circRNAs contributes to cancer progression. Cytokines are involved in regulating circRNA biogenesis. Furthermore, aberrantly expressed circRNAs regulate the expression of ligands, receptors, and downstream effectors involved in cytokine signaling to promote ...
Vandana Joshi+4 more
wiley +1 more source
Development and evaluation of curcumin nano-niosomes for glioma-targeted therapy. [PDF]
Qian H, Lv J, Hu X.
europepmc +1 more source
Targeted therapy against matrixmetalloproteinase, matrilysin.
Fumio Itoh, Kohzoh Imai
openalex +2 more sources